UPC
NASDAQ · Pharmaceuticals
Universe Pharmaceuticals Inc
$2.28
-0.04 (-1.72%)
Open$2.25
Previous Close$2.32
Day High$2.28
Day Low$2.19
52W High$11.00
52W Low$2.00
Volume—
Avg Volume6.0K
Market Cap1.39M
P/E Ratio—
EPS$-10.13
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.37M | 29.72M | 677.4K |
| Net Income | -4,394,934 | -5,499,013 | 91.7K |
| Profit Margin | -20.6% | -19.5% | 13.5% |
| EBITDA | -3,690,990 | -4,874,795 | 139.8K |
| Free Cash Flow | — | — | 93.2K |
| Rev Growth | -28.1% | -28.1% | +6.4% |
| Debt/Equity | 0.16 | 0.16 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |